Hypoglycemia – A Role in Criminal Behavior and a Consideration for Custodial Care

January 31, 2010

LONDON, February 1 /PRNewswire/ — The latest issue of the journal
Diabetic Hypoglycemia ( http://www.hypodiab.com) reviews the role of
hypoglycemia in provoking crimes and misdemeanors.

Professor Vincent Marks, a leading authority on the forensic aspects of
hypoglycemia and its role in criminal behavior, discusses how
hypoglycemia-related neuroglycopenia can cause behavioral changes, which can
bring people with diabetes into conflict with the law. “Hypoglycemia was
recognized as a cause of strange behavior that amounted in some cases to
criminality, within a few years of the introduction of insulin for treatment
of diabetes”, comments Professor Marks. He raises the question of whether a
person suffering from neuroglycopenia can formulate the intention to commit
an offence, going on to outline the medico-legal relevance of hypoglycemia,
and to discuss the less common offence of malicious administration of insulin
and/or a sulfonylurea as a weapon to induce hypoglycemic coma.

Professor Brian Frier’s related editorial describes the problem of
managing diabetes in people in police custody or long-term imprisonment.
Highlighting the fact that custodial conditions can be conducive to the
development of hypoglycemia in people with diabetes, Professor Frier suggests
that greater communication between diabetes specialist services and the
police and prison services should be encouraged, to assist their
understanding of this medical disorder and avoid the development of
significant hypoglycemia and perpetuation of suboptimal glycemic control in
such situations.

About Diabetic Hypoglycemia

We are pleased to announce that Diabetic Hypoglycemia will be indexed in
Elsevier’s prestigious EMBASE database, from 2010.

Diabetic Hypoglycemia is an influential online diabetes journal led by
Editor-in-Chief Professor Brian Frier (Edinburgh, UK), with Associate
Editors: Professor Simon Heller (Sheffield, UK), Professor Christopher Ryan (Pittsburgh, USA) and Dr Rory McCrimmon (Dundee, UK). Published three times
annually, Diabetic Hypoglycemia provides an interactive forum for the sharing
of practical knowledge and opinions in the field of hypoglycemia.

To explore Diabetic Hypoglycemia, please take the guided tour:

Diabetic Hypoglycemia is published by ESP Bioscience, supported by an
unrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark).

About ESP Bioscience

ESP Bioscience is a publisher of novel medical information products and
online medical communities, with headquarters in Sandhurst, United Kingdom.
Working in association with its academic partners in the global healthcare
community, ESP Bioscience publishes journals, books and online resources.


    Editorial Office
    E: enquiries@hypodiab.com
    T: +44-(0)1344-762531
    F: +44-(0)203-0514753

SOURCE ESP Bioscience

Source: newswire

comments powered by Disqus